Analysis of urinary exosomes applications for rare kidney disorders

References

• Schieppati A, Henter J-I, Daina E, et al. Why rare diseases are an important medical and social issue. Lancet. 2008;371(9629):2039–2041.
   PubMed Web of Science ®Google Scholar
• Devuyst O, Knoers NV, Remuzzi G, et al. Board of the working group for inherited kidney diseases of the European renal association and European dialysis and transplant association. Rare inherited kidney diseases: challenges, opportunities, and perspectives. Lancet. 2014;383(9931):1844–1859.
   PubMed Web of Science ®Google Scholar
• Liu BC, He L, He G, et al. A cross-national comparative study of orphan drug policies in the United States, the European Union, and Japan: towards a made-in-China orphan drug policy. J Public Health Policy. 2010;31(4):407–421.
   PubMed Web of Science ®Google Scholar
• Soliman NA. Orphan kidney diseases. Nephron Clin Pract. 2012;120(4):c194–9.
   PubMedGoogle Scholar
• Aymé S, Bockenhauer D, Day S, et al. Conference participants. Common elements in rare kidney diseases: conclusions from a kidney disease: improving global outcomes (KDIGO) controversies conference. Kidney Int. 2017;92(4):796–808.
   PubMed Web of Science ®Google Scholar
• Rogowski WH, Grosse SD, Khoury MJ. Challenges of translating genetic tests into clinical and public health practice. Nat Rev Genet. 2009;10(7):489–495.
   PubMed Web of Science ®Google Scholar
• Scott J, Trotter T. Primary care and genetics and genomics. Pediatrics. 2013;132(Suppl 3):S231–7.
   PubMed Web of Science ®Google Scholar
• Barbosa M, Joshi RS, Garg P, et al. Identification of rare de novo epigenetic variations in congenital disorders. Nat Commun. 2018;9(1):2064.
   PubMed Web of Science ®Google Scholar
• Denamur E, Delezoide AL, Alberti C, et al. Genotype-phenotype correlations in fetuses and neonates with autosomal recessive polycystic kidney disease. Kidney Int. 2010;77(4):350–358.
   PubMed Web of Science ®Google Scholar
• Eckardt K-U, Coresh J, Devuyst O, et al. Evolving importance of kidney disease: from subspecialty to global health burden. Lancet. 2013;382(9887):158–169.
   PubMed Web of Science ®Google Scholar
• Wilke M, Buijs-Offerman RM, Aarbiou J, et al. Mouse models of cystic fibrosis: phenotypic analysis and research applications. J Cyst Fibros. 2011 Jun;10(Suppl 2):S152–71.
   PubMed Web of Science ®Google Scholar
• Boyer O, Nevo F, Plaisier E, et al. INF2 mutations in Charcot-Marie-Tooth disease with glomerulopathy. N Engl J Med. 2011;365(25):2377–2388.
   PubMed Web of Science ®Google Scholar
• Kantarci S, Al-Gazali L, Hill RS, et al. Mutations in LRP2, which encodes the multiligand receptor megalin, cause Donnai-Barrow and facio-oculo-acoustico-renal syndromes. Nat Genet. 2007;39(8):957–959.
   PubMed Web of Science ®Google Scholar
• Emma F, Bertini E, Salviati L, et al. Renal involvement in mitochondrial cytopathies. Pediatr Nephrol. 2012;27:539–550.
   PubMed Web of Science ®Google Scholar
• Evans WR. Dare to think rare: diagnostic delay and rare diseases. Br J Gen Pract. 2018;68(670):224–225.
   PubMed Web of Science ®Google Scholar
• H Rashed M, Bayraktar E, K Helal G, et al. Exosomes: from garbage bins to promising therapeutic targets. Int J Mol Sci. 2017;18(3):538.
   Web of Science ®Google Scholar
• Record M, Carayon K, Poirot M, et al. Exosomes as new vesicular lipid transporters involved in cell-cell communication and various pathophysiologies. Biochim Biophys Acta. 2014;1841(1):108–120.
   PubMed Web of Science ®Google Scholar
• Mathivanan S, Ji H, Simpson RJ. Exosomes: extracellular organelles important in intercellular communication. J Proteomics. 2010;73(10):1907–1920.
   PubMed Web of Science ®Google Scholar
• Raposo G, Stoorvogel W. Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol. 2013;200(4):373–383.
   PubMed Web of Science ®Google Scholar
• Maas SLN, Breakefield XO, Weaver AM. Extracellular vesicles: unique intercellular delivery vehicles. Trends Cell Biol. 2017;27(3):172–188.
   PubMed Web of Science ®Google Scholar
• Kowal J, Tkach M, Théry C. Biogenesis and secretion of exosomes. Curr Opin Cell Biol. 2014;29:116–125.
   PubMed Web of Science ®Google Scholar
• Simpson RJ, Jensen SS, Lim JW. Proteomic profiling of exosomes: current perspectives. Proteomics. 2008;8(19):4083–4099.
   PubMed Web of Science ®Google Scholar
• Valadi H, Ekström K, Bossios A, et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007;9(6):654–659.
   PubMed Web of Science ®Google Scholar
• Pegtel DM, Cosmopoulos K, Thorley-Lawson DA, et al. Functional delivery of viral miRNAs via exosomes. Proc Natl Acad Sci U S A. 2010;107(14):6328–6333.
   PubMed Web of Science ®Google Scholar
• Keerthikumar S, Chisanga D, Ariyaratne D, et al. ExoCarta: a web-based compendium of exosomal cargo. J Mol Biol. 2016;428(4):688–692.
   PubMed Web of Science ®Google Scholar
• Gracia T, Wang X, Su Y, et al. Urinary exosomes contain MicroRNAs capable of paracrine modulation of tubular transporters in kidney. Sci Rep. 2017;7:40601.
   PubMed Web of Science ®Google Scholar
• Doyle LM, Wang MZ. Overview of extracellular vesicles, their origin, composition, purpose, and methods for exosome isolation and analysis. Cells. 2019;8(7):727.
   PubMed Web of Science ®Google Scholar
• Trajkovic K, Hsu C, Chiantia S, et al. Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science. 2008;319(5867):1244–1247.
   PubMed Web of Science ®Google Scholar
• Hessvik NP, Llorente A. Current knowledge on exosome biogenesis and release. Cell Mol Life Sci. 2018;75(2):193–208.
   PubMed Web of Science ®Google Scholar
• Bang C, Thum T. Exosomes: new players in cell-cell communication. Int J Biochem Cell Biol. 2012;44(11):2060–2064.
   PubMed Web of Science ®Google Scholar
• Vlassov AV, Magdaleno S, Setterquist R, et al. Exosomes: current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials. Biochim Biophys Acta. 2012;1820(7):940–948.
   PubMed Web of Science ®Google Scholar
• Escola JM, Kleijmeer MJ, Stoorvogel W, et al. Selective enrichment of tetraspan proteins on the internal vesicles of multivesicular endosomes and on exosomes secreted by human B-lymphocytes. J Biol Chem. 1998;273(32):20121–20127.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Liu Y, Liu H, et al. Exosomes: biogenesis, biologic function and clinical potential. Cell Biosci. 2019 Feb 15;9:19.
   PubMed Web of Science ®Google Scholar
• King HW, Michael MZ, Gleadle JM. Hypoxic enhancement of exosome release by breast cancer cells. BMC Cancer. 2012 Sep 24;12:421.
   PubMed Web of Science ®Google Scholar
• Patton MC, Zubair H, Khan MA, et al. Hypoxia alters the release and size distribution of extracellular vesicles in pancreatic cancer cells to support their adaptive survival. J Cell Biochem. 2020;121(1):828–839.
   PubMed Web of Science ®Google Scholar
• Pomatto MAC, Gai C, Bussolati B, et al. Extracellular vesicles in renal pathophysiology. Front Mol Biosci. 2017;4:37.
   PubMed Web of Science ®Google Scholar
• Turturici G, Tinnirello R, Sconzo G, et al. Extracellular membrane vesicles as a mechanism of cell-to-cell communication: advantages and disadvantages. Am J Physiol Cell Physiol. 2014;306(7):C621–33.
   PubMed Web of Science ®Google Scholar
• Tian T, Wang Y, Wang H, et al. Visualizing of the cellular uptake and intracellular trafficking of exosomes by live-cell microscopy. J Cell Biochem. 2010;111(2):488–496.
   PubMed Web of Science ®Google Scholar
• Li P, Kaslan M, Lee SH, et al. Progress in exosome isolation techniques. Theranostics. 2017;7(3):789–804.
   PubMed Web of Science ®Google Scholar
• Yan Z, Dutta S, Liu Z, et al. A label-free platform for identification of exosomes from different sources. ACS Sens. 2019;4(2):488–497.
   PubMed Web of Science ®Google Scholar
• Abramowicz A, Widlak P, Pietrowska M. Proteomic analysis of exosomal cargo: the challenge of high purity vesicle isolation. Mol Biosyst. 2016;12(5):1407–1419.
   PubMedGoogle Scholar
• Panfoli I, Candiano G, Malova M, et al. Oxidative stress as a primary risk factor for brain damage in preterm newborns. Front Pediatr. 2018;6:369.
   PubMed Web of Science ®Google Scholar
• Vall-Palomar M, Arévalo J, Ariceta G, et al. Establishment of urinary exosome-like vesicles isolation protocol for FHHNC patients and evaluation of different exosomal RNA extraction methods. J Transl Med. 2018;16(1):278.
   PubMed Web of Science ®Google Scholar
• Lobb RJ, Becker M, Wen SW, et al. Optimized exosome isolation protocol for cell culture supernatant and human plasma. J Extracell Vesicles. 2015;4:27031.
   PubMed Web of Science ®Google Scholar
• Zeringer E, Barta T, Li M, et al. Strategies for isolation of exosomes. Cold Spring Harb Protoc. 2015 Apr 1;2015(4):319–323.
   PubMedGoogle Scholar
• Alvarez ML, Khosroheidari M, Kanchi Ravi R, et al. Comparison of protein, microRNA, and mRNA yields using different methods of urinary exosome isolation for the discovery of kidney disease biomarkers. Kidney Int. 2012;82(9):1024–1032.
   PubMed Web of Science ®Google Scholar
• Paolini L, Zendrini A, Di Noto G, et al. Residual matrix from different separation techniques impacts exosome biological activity. Sci Rep. 2016;6:23550.
   PubMed Web of Science ®Google Scholar
• Baranyai T, Herczeg K, Onódi Z, et al. Isolation of exosomes from blood plasma: qualitative and quantitative comparison of ultracentrifugation and size exclusion chromatography methods. PLoS One. 2015;10(12):e0145686.
   PubMed Web of Science ®Google Scholar
• Muller L, Hong CS, Stolz DB, et al. Isolation of biologically-active exosomes from human plasma. J Immunol Methods. 2014;411:55–65.
   PubMed Web of Science ®Google Scholar
• Nordin JZ, Lee Y, Vader P, et al. Ultrafiltration with size-exclusion liquid chromatography for high yield isolation of extracellular vesicles preserving intact biophysical and functional properties. Nanomedicine. 2015;11(4):879–883.
   PubMed Web of Science ®Google Scholar
• Böing AN, van der Pol E, Grootemaat AE, et al. Single-step isolation of extracellular vesicles by size-exclusion chromatography. J Extracell Vesicles. 2014;3:10.3402/jev.v3.23430
   Google Scholar
• Momen-Heravi F, Balaj L, Alian S, et al. Current methods for the isolation of extracellular vesicles. Biol Chem. 2013;394(10):1253–1262.
   PubMed Web of Science ®Google Scholar
• Contreras-Naranjo JC, Wu HJ, Ugaz VM. Microfluidics for exosome isolation and analysis: enabling liquid biopsy for personalized medicine. Lab Chip. 2017;17(21):3558–3577.
   PubMed Web of Science ®Google Scholar
• Liu C, Guo J, Tian F, et al. Field-free isolation of exosomes from extracellular vesicles by microfluidic viscoelastic flows. ACS Nano. 2017;11(7):6968–6976.
   PubMed Web of Science ®Google Scholar
• Kanwar SS, Dunlay CJ, Simeone DM, et al. Microfluidic device (ExoChip) for on-chip isolation, quantification and characterization of circulating exosomes. Lab Chip. 2014;14(11):1891–1900.
   PubMed Web of Science ®Google Scholar
• Wu M, Ouyang Y, Wang Z, et al. Isolation of exosomes from whole blood by integrating acoustics and microfluidics. Proc Natl Acad Sci U S A. 2017;114(40):10584–10589.
   PubMed Web of Science ®Google Scholar
• Veziroglu EM, Mias GI. Characterizing extracellular vesicles and their diverse RNA contents. Front Genet. 2020;11:700.
   PubMed Web of Science ®Google Scholar
• Coumans FAW, Brisson AR, Buzas EI, et al. Methodological guidelines to study extracellular vesicles. Circ Res. 2017;120(10):1632–1648.
   PubMed Web of Science ®Google Scholar
• Li G, Tang W, Yang F. Cancer liquid biopsy using integrated microfluidic exosome analysis platforms. Biotechnol J. 2020;15(5):e1900225.
   PubMed Web of Science ®Google Scholar
• Woo HK, Sunkara V, Park J, et al. Exodisc for rapid, size-selective, and efficient isolation and analysis of nanoscale extracellular vesicles from biological samples. ACS Nano. 2017;11(2):1360–1370.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Bi J, Huang J, et al. Exosome: a review of its classification, isolation techniques, storage, diagnostic and targeted therapy applications. Int J Nanomedicine. 2020 Sep 22;15:6917–6934.
   PubMed Web of Science ®Google Scholar
• Huang Y, Cheng L, Turchinovich A, et al. Influence of species and processing parameters on recovery and content of brain tissue-derived extracellular vesicles. J Extracell Vesicles. 2020 Jun 30;9(1):1785746.
   PubMed Web of Science ®Google Scholar
• Ge Q, Zhou Y, Lu J, et al. miRNA in plasma exosome is stable under different storage conditions. Molecules. 2014 Jan 27;19(2):1568–1575.
   PubMed Web of Science ®Google Scholar
• Maroto R, Zhao Y, Jamaluddin M, et al. Effects of storage temperature on airway exosome integrity for diagnostic and functional analyses. J Extracell Vesicles. 2017 Aug 13;6(1):1359478.
   PubMed Web of Science ®Google Scholar
• Huebner AR, Somparn P, Benjachat T, et al. Exosomes in urine biomarker discovery. Adv Exp Med Biol. 2015;845:43–58.
   PubMed Web of Science ®Google Scholar
• Fenton RA. Proteomic approaches in kidney disease biomarker discovery. Am J Physiol Renal Physiol. 2018;315(6):F1817–21.
   PubMed Web of Science ®Google Scholar
• Ståhl AL, Johansson K, Mossberg M, et al. Exosomes and microvesicles in normal physiology, pathophysiology, and renal diseases. Pediatr Nephrol. 2019;34(1):11–30.
   PubMed Web of Science ®Google Scholar
• Knepper MA, Pisitkun T. Exosomes in urine: who would have thought …? Kidney Int. 2007 Nov;72(9):1043–1045.
   PubMed Web of Science ®Google Scholar
• Franzen CA, Blackwell RH, Foreman KE, et al. Urinary exosomes: the potential for biomarker utility, intercellular signaling and therapeutics in urological malignancy. J Urol. 2016 May;195(5):1331–1339.
   PubMed Web of Science ®Google Scholar
• Gámez-Valero A, Lozano-Ramos SI, Bancu I, et al. Urinary extracellular vesicles as source of biomarkers in kidney diseases. Front Immunol. 2015 Jan 30;6:6.
   PubMed Web of Science ®Google Scholar
• Prunotto M, Farina A, Lane L, et al. Proteomic analysis of podocyte exosome-enriched fraction from normal human urine. J Proteomics. 2013;82:193–229.
   PubMed Web of Science ®Google Scholar
• Salih M, Zietse R, Hoorn EJ. Urinary extracellular vesicles and the kidney: biomarkers and beyond. Am J Physiol Renal Physiol. 2014;306(11):F1251–9.
   PubMed Web of Science ®Google Scholar
• Gildea JJ, Seaton JE, Victor KG, et al. Exosomal transfer from human renal proximal tubule cells to distal tubule and collecting duct cells. Clin Biochem. 2014;47(15):89–94.
   PubMed Web of Science ®Google Scholar
• Morrison EE, Bailey MA, Dear JW. Renal extracellular vesicles: from physiology to clinical application. J Physiol. 2016;594(20):5735–5748.
   PubMed Web of Science ®Google Scholar
• Merchant ML, Rood IM, Deegens JKJ, et al. Isolation and characterization of urinary extracellular vesicles: implications for biomarker discovery. Nat Rev Nephrol. 2017;13(12):731–749.
   PubMed Web of Science ®Google Scholar
• Street JM, Birkhoff W, Menzies RI, et al. Exosomal transmission of functional aquaporin 2 in kidney cortical collecting duct cells. J Physiol. 2011;589(Pt 24):6119–6127.
   PubMed Web of Science ®Google Scholar
• Radin MJ, Yu MJ, Stoedkilde L, et al. Aquaporin-2 regulation in health and disease. Vet Clin Pathol. 2012;41(4):455–470.
   PubMed Web of Science ®Google Scholar
• Miyazawa Y, Mikami S, Yamamoto K, et al. AQP2 in human urine is predominantly localized to exosomes with preserved water channel activities. Clin Exp Nephrol. 2018;22(4):782–788.
   PubMed Web of Science ®Google Scholar
• Jella KK, Yu L, Yue Q, et al. Exosomal GAPDH from proximal tubule cells regulate ENaC activity. PLoS One. 2016;11(11):e0165763.
   PubMed Web of Science ®Google Scholar
• Oosthuyzen W, Scullion KM, Ivy JR, et al. Vasopressin regulates extracellular vesicle uptake by kidney collecting duct cells. J Am Soc Nephrol. 2016;27(11):3345–3355.
   PubMed Web of Science ®Google Scholar
• Borges FT, Melo SA, Özdemir BC, et al. TGF-β1-containing exosomes from injured epithelial cells activate fibroblasts to initiate tissue regenerative responses and fibrosis. J Am Soc Nephrol. 2013;24(3):385–392.
   PubMed Web of Science ®Google Scholar
• Hiemstra TF, Charles PD, Gracia T, et al. Human urinary exosomes as innate immune effectors. J Am Soc Nephrol. 2014;25(9):2017–2027.
   PubMed Web of Science ®Google Scholar
• Chun-Yan L, Zi-Yi Z, Tian-Lin Y, et al. Liquid biopsy biomarkers of renal interstitial fibrosis based on urinary exosome. Exp Mol Pathol. 2018;105(2):223–228.
   PubMed Web of Science ®Google Scholar
• Pisitkun T, Shen RF, Knepper MA. Identification and proteomic profiling of exosomes in human urine. Proc Natl Acad Sci U S A. 2004;101(36):13368–13373.
   PubMed Web of Science ®Google Scholar
• Sun IO, Lerman LO. Urinary extracellular vesicles as biomarkers of kidney disease: from diagnostics to therapeutics. Diagnostics (Basel). 2020;10(5):311.
   Google Scholar
• Bruschi M, Granata S, Santucci L, et al. proteomic analysis of urinary microvesicles and exosomes in medullary sponge kidney disease and autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol. 2019;14(6):834–843.
   PubMed Web of Science ®Google Scholar
• Thongboonkerd V. Roles for exosome in various kidney diseases and disorders. Front Pharmacol. 2020;10:1655.
   PubMed Web of Science ®Google Scholar
• Solazzo A, Testa F, Giovanella S, et al. The prevalence of autosomal dominant polycystic kidney disease (ADPKD): A meta-analysis of European literature and prevalence evaluation in the Italian province of Modena suggest that ADPKD is a rare and underdiagnosed condition. PLoS One. 2018;13(1):e0190430.
   PubMed Web of Science ®Google Scholar
• Mochizuki T, Wu G, Hayashi T, et al. PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science. 1996;272(5266):1339–1342.
   PubMed Web of Science ®Google Scholar
• Harris PC. Molecular basis of polycystic kidney disease: PKD1, PKD2 and PKHD1. Curr Opin Nephrol Hypertens. 2002;11(3):309–314.
   PubMed Web of Science ®Google Scholar
• Kim S, Nie H, Nesin V, et al. The polycystin complex mediates Wnt/Ca(2+) signalling. Nat Cell Biol. 2016;18(7):752–764.
   PubMed Web of Science ®Google Scholar
• Yoder BK, Hou X, Guay-Woodford LM. The polycystic kidney disease proteins, polycystin-1, polycystin-2, polaris, and cystin, are co-localized in renal cilia. J Am Soc Nephrol. 2002;13(10):2508–2516.
   PubMed Web of Science ®Google Scholar
• Nauli SM, Alenghat FJ, Luo Y, et al. Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells. Nat Genet. 2003;33(2):129–137.
   PubMed Web of Science ®Google Scholar
• Hogan MC, Manganelli L, Woollard JR, et al. Characterization of PKD protein-positive exosome-like vesicles. J Am Soc Nephrol. 2009;20(2):278–288.
   PubMed Web of Science ®Google Scholar
• Chacon-Heszele MF, Choi SY, Zuo X, et al. The exocyst and regulatory GTPases in urinary exosomes. Physiol Rep. 2014;2(8):e12116.
   PubMedGoogle Scholar
• Ward CJ, Hogan MC, Rossetti S, et al. The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein. Nat Genet. 2002;30(3):259–69
   PubMed Web of Science ®Google Scholar
• Onuchic LF, Furu L, Nagasawa Y, et al. PKHD1, the polycystic kidney and hepatic disease 1 gene, encodes a novel large protein containing multiple immunoglobulin-like plexin-transcription-factor domains and parallel beta-helix 1 repeats. Am J Hum Genet. 2002;70(5):1305–1317.
   PubMed Web of Science ®Google Scholar
• Bergmann C, Guay-Woodford LM, Harris PC, et al. Polycystic kidney disease. Nat Rev Dis Primers. 2018;4(1):50.
   PubMed Web of Science ®Google Scholar
• Salih M, Demmers JA, Bezstarosti K, et al. DIPAK consortium. Proteomics of urinary vesicles links plakins and complement to polycystic kidney disease. J Am Soc Nephrol. 2016;27(10):3079–3092.
   PubMed Web of Science ®Google Scholar
• Hogan MC, Bakeberg JL, Gainullin VG, et al. Identification of biomarkers for PKD1 using urinary exosomes. J Am Soc Nephrol. 2015;26(7):1661–1670.
   PubMed Web of Science ®Google Scholar
• Gambaro G, Danza FM, Fabris A. Medullary sponge kidney. Curr Opin Nephrol Hypertens. 2013;22(4):421–426.
   PubMed Web of Science ®Google Scholar
• Fabris A, Lupo A, Ferraro PM, et al. Familial clustering of medullary sponge kidney is autosomal dominant with reduced penetrance and variable expressivity. Kidney Int. 2013;83(2):272–277.
   PubMed Web of Science ®Google Scholar
• Torregrossa R, Anglani F, Fabris A, et al. Identification of GDNF gene sequence variations in patients with medullary sponge kidney disease. Clin J Am Soc Nephrol. 2010;5(7):1205–1210.
   PubMed Web of Science ®Google Scholar
• Fabris A, Bruschi M, Santucci L, et al. Proteomic-based research strategy identified laminin subunit alpha 2 as a potential urinary-specific biomarker for the medullary sponge kidney disease. Kidney Int. 2017;91(2):459–468.
   PubMed Web of Science ®Google Scholar
• Ria P, Fabris A, Dalla Gassa A, et al. New non-renal congenital disorders associated with medullary sponge kidney (MSK) support the pathogenic role of GDNF and point to the diagnosis of MSK in recurrent stone formers. Urolithiasis. 2017;45(4):359–362.
   PubMed Web of Science ®Google Scholar
• Fabris A, Ferraro PM, Comellato G, et al. The relationship between calcium kidney stones, arterial stiffness and bone density: unraveling the stone-bone-vessel liaison. J Nephrol. 2015;28(5):549–555.
   PubMed Web of Science ®Google Scholar
• Lambrianides AL, John DR. Medullary sponge disease in horseshoe kidney. Urology. 1987;29(4):426–427.
   PubMed Web of Science ®Google Scholar
• Bruschi M, Granata S, Candiano G, et al. Proteomic analysis of urinary extracellular vesicles reveals a role for the complement system in medullary sponge kidney disease. Int J Mol Sci. 2019;20(21):5517.
   Web of Science ®Google Scholar
• Saravakos P, Kokkinou V, Giannatos E. Cystinuria: current diagnosis and management. Urology. 2014;83(4):693–699.
   PubMed Web of Science ®Google Scholar
• Servais A, Thomas K, Strologo LD, et al. Metabolic nephropathy workgroup of the European reference network for rare kidney diseases (ERKNet) and eUROGEN. Cystinuria: clinical practice recommendation. Kidney Int. 2020. S0085-2538(20)30829-2.
   Google Scholar
• Bourderioux M, Nguyen-Khoa T, Chhuon C, et al. A new workflow for proteomic analysis of urinary exosomes and assessment in cystinuria patients. J Proteome Res. 2015;14(1):567–577.
   PubMed Web of Science ®Google Scholar
• Hoorn EJ, Pisitkun T, Zietse R, et al. Prospects for urinary proteomics: exosomes as a source of urinary biomarkers. Nephrology (Carlton). 2005;10(3):283–290.
   PubMed Web of Science ®Google Scholar
• Tsokos GC, Lo MS, Costa Reis P, et al. New insights into the immunopathogenesis of systemic lupus erythematosus. Nat Rev Rheumatol. 2016;12(12):716–730.
   PubMed Web of Science ®Google Scholar
• Almaani S, Meara A, Rovin BH. Update on lupus nephritis. Clin J Am Soc Nephrol. 2017;12(5):825–835.
   PubMed Web of Science ®Google Scholar
• Ichii O, Otsuka-Kanazawa S, Horino T, et al. Decreased miR-26a expression correlates with the progression of podocyte injury in autoimmune glomerulonephritis. PLoS One. 2014;9(10):e110383.
   PubMed Web of Science ®Google Scholar
• Perez-Hernandez J, Forner MJ, Pinto C, et al. Increased urinary exosomal MicroRNAs in patients with systemic lupus erythematosus. PLoS One. 2015;10(9):e0138618.
   PubMed Web of Science ®Google Scholar
• Perez-Hernandez J, Martinez-Arroyo O, Ortega A, et al. Urinary exosomal miR-146a as a marker of albuminuria, activity changes and disease flares in lupus nephritis. J Nephrol. 2020. doi: 10.1007/s40620-020-00832-y.
   PubMed Web of Science ®Google Scholar
• Qin W, Chung AC, Huang XR, et al. TGF-β/Smad3 signaling promotes renal fibrosis by inhibiting miR-29. J Am Soc Nephrol. 2011;22(8):1462–1474.
   PubMed Web of Science ®Google Scholar
• Solé C, Cortés-Hernández J, Felip ML, et al. miR-29c in urinary exosomes as predictor of early renal fibrosis in lupus nephritis. Nephrol Dial Transplant. 2015;30(9):1488–1496.
   PubMed Web of Science ®Google Scholar
• Tangtanatakul P, Klinchanhom S, Sodsai P, et al. Down-regulation of let-7a and miR-21 in urine exosomes from lupus nephritis patients during disease flare. Asian Pac J Allergy Immunol. 2019;37(4):189–197.
   PubMed Web of Science ®Google Scholar
• Costa-Reis P, Russo PA, Zhang Z, et al. The role of MicroRNAs and human epidermal growth factor Receptor 2 in proliferative lupus nephritis. Arthritis Rheumatol. 2015;67(9):2415–2426.
   PubMed Web of Science ®Google Scholar
• Chau BN, Xin C, Hartner J, et al. MicroRNA-21 promotes fibrosis of the kidney by silencing metabolic pathways. Sci Transl Med. 2012;4(121):121ra18.
   PubMed Web of Science ®Google Scholar
• Solé C, Moliné T, Vidal M, et al. An exosomal urinary miRNA signature for early diagnosis of renal fibrosis in lupus nephritis. Cells. 2019;8(8):773.
   PubMed Web of Science ®Google Scholar
• Zhou H, Hasni SA, Perez P, et al. miR-150 promotes renal fibrosis in lupus nephritis by downregulating SOCS1. J Am Soc Nephrol. 2013;24(7):1073–1087.
   PubMed Web of Science ®Google Scholar
• Li Y, Xu X, Tang X, et al. MicroRNA expression profile of urinary exosomes in Type IV lupus nephritis complicated by cellular crescent. J Biol Res (Thessalon). 2018;25:16.
   PubMed Web of Science ®Google Scholar
• Lu M, Wang C, Chen W, et al. miR-654-5p targets GRAP to promote proliferation, metastasis, and chemoresistance of oral squamous cell carcinoma through Ras/MAPK signaling. DNA Cell Biol. 2018;37(4):381–388.
   PubMed Web of Science ®Google Scholar
• Liu W, Ling S, Sun W, et al. Circulating microRNAs correlated with the level of coronary artery calcification in symptomatic patients. Sci Rep. 2015;5:16099.
   PubMed Web of Science ®Google Scholar
• Garcia-Vives E, Solé C, Moliné T, et al. The urinary exosomal miRNA expression profile is predictive of clinical response in lupus nephritis. Int J Mol Sci. 2020;21(4):1372.
   Web of Science ®Google Scholar
• McGrogan A, Franssen CF, de Vries CS. The incidence of primary glomerulonephritis worldwide: a systematic review of the literature. Nephrol Dial Transplant. 2011;26(2):414–430.
   PubMed Web of Science ®Google Scholar
• Roberts IS. Pathology of IgA nephropathy. Nat Rev Nephrol. 2014;10(8):445–454.
   PubMed Web of Science ®Google Scholar
• Morikawa Y, Takahashi N, Kamiyama K, et al. Elevated levels of urinary extracellular vesicle fibroblast-specific Protein 1 in patients with active crescentic glomerulonephritis. Nephron. 2019;141(3):177–187.
   PubMed Web of Science ®Google Scholar
• Feng Y, Lv LL, Wu WJ, et al. Urinary exosomes and exosomal CCL2 mRNA as biomarkers of active histologic injury in IgA nephropathy. Am J Pathol. 2018;188(11):2542–2552.
   PubMed Web of Science ®Google Scholar
• Moon PG, Lee JE, You S, et al. Proteomic analysis of urinary exosomes from patients of early IgA nephropathy and thin basement membrane nephropathy. Proteomics. 2011;11(12):2459–2475.
   PubMed Web of Science ®Google Scholar
• Huang Z, Zhang Y, Zhou J, et al. Urinary exosomal miR-193a can be a potential biomarker for the diagnosis of primary focal segmental glomerulosclerosis in children. Biomed Res Int. 2017;2017:7298160.
   PubMed Web of Science ®Google Scholar
• Dong L, Pietsch S, Englert C. Towards an understanding of kidney diseases associated with WT1 mutations. Kidney Int. 2015;88(4):684–690.
   PubMed Web of Science ®Google Scholar
• Zhou H, Cheruvanky A, Hu X, et al. Urinary exosomal transcription factors, a new class of biomarkers for renal disease. Kidney Int. 2008;74(5):613–621.
   PubMed Web of Science ®Google Scholar
• Lee H, Han KH, Lee SE, et al. Urinary exosomal WT1 in childhood nephrotic syndrome. Pediatr Nephrol. 2012;27(2):317–320.
   PubMed Web of Science ®Google Scholar
• Chen T, Wang C, Yu H, et al. Increased urinary exosomal microRNAs in children with idiopathic nephrotic syndrome. EBioMedicine. 2019;39:552–561.
   PubMed Web of Science ®Google Scholar
• Corbetta S, Raimondo F, Tedeschi S, et al. Urinary exosomes in the diagnosis of gitelman and bartter syndromes. Nephrol Dial Transplant. 2015;30(4):621–630.
   PubMed Web of Science ®Google Scholar
• Gonzales PA, Pisitkun T, Hoffert JD, et al. Large-scale proteomics and phosphoproteomics of urinary exosomes. J Am Soc Nephrol. 2009;20(2):363–379.
   PubMed Web of Science ®Google Scholar
• Raimondo F, Chinello C, Porcaro L, et al. Urinary extracellular vesicles and salt-losing tubulopathies: a proteomic approach. Proteomes. 2020;8(2):9.
   PubMed Web of Science ®Google Scholar
• Staubach S, Wenzel A, Beck BB, et al. Autosomal tubulointerstitial kidney disease-MUC1 type: differential proteomics suggests that mutated MUC1 (insC) affects vesicular transport in renal epithelial cells. Proteomics. 2018;18(7):e1700456.
   PubMed Web of Science ®Google Scholar
• Zaza G, Granata S, Sallustio F, et al. Pharmacogenomics: a new paradigm to personalize treatments in nephrology patients. Clin Exp Immunol. 2010;159(3):268–280.
   PubMed Web of Science ®Google Scholar
• Zaza G, Granata S, Tomei P, et al. Personalization of the immunosuppressive treatment in renal transplant recipients: the great challenge in “omics” medicine. Int J Mol Sci. 2015;16(2):4281–4305.
   PubMed Web of Science ®Google Scholar